Esflurbiprofen
MUSCULO-SKELETAL SYSTEM
Also known as: loqoa, TT-063
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Esflurbiprofen is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2015. DrugCentral lists 2 molecular targets, including Ptgs1 and PTGS2. Recorded indications include Osteoarthritis.
- Molecular targets: Ptgs1 and PTGS2 (2 listed in DrugCentral).
- Indications: Osteoarthritis.
- ATC code: M02AA29 (Antiinflammatory preparations, non-steroids for topical use).
- Molecular formula: C15H13FO2; molecular weight 244.26 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Osteoarthritis
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ptgs1 | unknown | IC50 7.52 |
| Prostaglandin G/H synthase 2 | PTGS2 | unknown | IC50 6.04 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2015-09-28 | PMDA | — | Taisho Pharmaceutical Co., Ltd. |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
M02AA29 | MUSCULO-SKELETAL SYSTEM › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › Antiinflammatory preparations, non-steroids for topical use |
Chemical structure
| Molecular formula | C15H13FO2 |
|---|---|
| Molecular weight | 244.26 g/mol |
| CAS number | 51543-39-6 |
| InChIKey | SYTBZMRGLBWNTM-JTQLQIEISA-N |
| PubChem CID | 72099 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Esflurbiprofen used for?
DrugCentral lists the following indications for Esflurbiprofen: Osteoarthritis.
How does Esflurbiprofen work?
Its molecular targets in DrugCentral include Ptgs1 and PTGS2.
When was Esflurbiprofen first approved?
Esflurbiprofen was first approved by the PMDA in 2015.
What is the chemical formula of Esflurbiprofen?
Esflurbiprofen has the molecular formula C15H13FO2 and a molecular weight of 244.26 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5060 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL435298 — compound record and bioactivity
- PubChem CID 72099 — chemical identifiers
- DrugBank DB16159 — drug record
- FDA UNII J5ZZK9P7MX — substance identity
- UniProt P35354 (PTGS2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.